“Motif Prediction of Abemaciclib in a Breast Cancer Cell Line Using ChIP-Seq Data Analysis”. Biomedical Research and Therapy, vol. 9, no. 3, Mar. 2022, pp. 4971-85, https://doi.org/10.15419/bmrat.v9i3.732.